Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers with corporate access will find a wealth of contextualized life science insight ready to be viewed in the FENIX Marketplace.
Welcome to FENIX Syndicated Services. If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact us.
$599
Posted in: Glucose Monitoring, Insulin Delivery Nov 20 | 2018Medtronic CY Q3 '18 (FY Q2 '19) Earnings UpdatePurchase Blast$599
Posted in: Glucose Monitoring Nov 19 | 2018Verily/Novartis Halts Glucose Sensing Contact Lens DevelopmentPurchase Blast$599
Posted in: Glucagon Nov 15 | 2018Zealand Q3 '18 Earnings; Xeris Initiates New Ph3 Study vs. GlucaGenPurchase Blast
Free
Posted in: Other Nov 14 | 2018Amarin’s REDUCE-IT: Winners, Losers, and Suitors AnalysisAccess Free Blast$599
Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, Dual/triple agonist, GLP-1RA, GLP-1RA + Basal, Glucagon, Glucose Monitoring, Insulin Delivery, Other, SGLT2i Nov 11 | 2018Thoughts on the Regulatory Environment in DiabetesPurchase Blast$599
Posted in: SGLT2i Nov 11 | 2018DECLARE Disappoints, Yet Creates Many ImplicationsPurchase Blast$599
Posted in: Glucose Monitoring Nov 08 | 2018Senseonics Q3 '18 Earnings Update; Abbott FreeStyle Link Now AvailablePurchase Blast$599
Posted in: DPP-IVi, GLP-1RA, SGLT2i Nov 08 | 2018Farxiga T1DM US Filing in Q4 '18; AZ Q3 '18 Earnings UpdatePurchase Blast$599
Posted in: Insulin Delivery Nov 07 | 2018Insulet Partners with Samsung for Smartphone Pump ControlPurchase Blast$599
Posted in: Glucose Monitoring, Insulin Delivery Nov 06 | 2018New Dexcom Approvals; Dexcom and BD Q3 '18 Earnings UpdatesPurchase Blast$599
Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, Dual/triple agonist, GLP-1RA, Glucagon, SGLT2i Nov 06 | 2018REWIND Safety Issue? Lilly Q3 '18 Earnings UpdatePurchase Blast$599
Posted in: Dual/triple agonist, GLP-1RA Nov 05 | 2018Positive Trulicity CVOT Creates Many Market ImplicationsPurchase Blast$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA Nov 02 | 2018New Lilly and Novo Trials: Trulicity vs. Ozempic Pens, Fiasp U200, and QW InsulinPurchase Blast$599
Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, GLP-1RA + Basal, Glucagon Nov 02 | 2018Novo Q3 ’18 London Earnings EventPurchase Blast$599
Posted in: Glucose Monitoring Nov 02 | 2018UPDATED: No Approval for Dexcom Verily G1Purchase Blast$599
Posted in: Glucose Monitoring, Insulin Delivery Nov 01 | 2018Insulet and Tandem Q3 '18 Earnings UpdatesPurchase Blast$599
Posted in: Bolus Insulin, SGLT2i Nov 01 | 2018Lexicon and MannKind Q3 '18 Earnings UpdatesPurchase Blast